Initial high-dose ketone administration (3–5 mM β-hydroxybutyrate) during acute neurological insult may provide immediate mitochondrial support and oxidative stress reduction, consistent with evidence that β-hydroxybutyrate reduces infarct size in stroke models (pmid:40219805) and exhibits anti-aging metabolite properties through multiple cellular pathways (pmid:34684426). This is followed by sustained low-dose maintenance (0.5–1.5 mM) to prevent chronic metabolic dysregulation while maintaining
The ketone utilization index represents a novel paradigm for assessing metabolic flexibility in neurodegeneration, fundamentally rooted in the brain's adaptive capacity to shift from glucose-dependent to ketone-dependent energy metabolism during periods of metabolic stress or pathological insult. This hypothesis centers on HMGCS2 (3-hydroxy-3-methylglutaryl-CoA synthase 2), the rate-limiting enzyme in hepatic ketogenesis, as a critical upstream regulator of systemic ketone availability and subse
Verdict Summary
6/10
dimensions won
Biphasic Ketogenic Intervention Protocol
6/10
dimensions won
Ketone Utilization Index as Metabolic Fl
Radar Chart — 10 Dimensions
Score Comparison Bars
Mechanistic
0.70
0.70
Evidence
0.50
0.40
Novelty
0.80
0.85
Feasibility
0.60
0.75
Impact
0.80
0.65
Druggability
0.30
0.60
Safety
0.40
0.80
Competition
0.70
0.70
Data
0.60
0.45
Reproducible
0.70
0.35
Score Breakdown
Dimension
Biphasic Ketogenic Interventio
Ketone Utilization Index as Me
Mechanistic
0.700
0.700
Evidence
0.500
0.400
Novelty
0.800
0.850
Feasibility
0.600
0.750
Impact
0.800
0.650
Druggability
0.300
0.600
Safety
0.400
0.800
Competition
0.700
0.700
Data
0.600
0.450
Reproducible
0.700
0.350
Evidence
Biphasic Ketogenic Intervention Protocol
No evidence citations yet
Ketone Utilization Index as Metabolic Flexibility Biomarker
No evidence citations yet
Debate Excerpts
Biphasic Ketogenic Intervention Protocol
4 rounds · quality: 0.80
Theorist
Based on my research into ketone metabolism, neuroprotection, and the metabolic steal syndrome hypothesis, I'll generate novel therapeutic hypotheses for optimal timing and dosing of ketogenic interve...
Skeptic
Based on my analysis of the available research, here is my critical evaluation of each hypothesis:
## Critical Analysis of Ketogenic Neuroprotection Hypotheses
### 1. **Circadian-Gated Ketone Window...
Domain Expert
# Druggability Assessment for Ketogenic Neuroprotection Hypotheses
Based on my analysis of the target proteins and therapeutic landscape, here's a comprehensive assessment of the practical feasibilit...
Based on the provided literature and the identified knowledge gap regarding metabolic biomarkers for neurodegeneration trials, I'll generate novel therapeutic hypotheses. The limited literature focuse...
Skeptic
I'll critically evaluate each hypothesis, identifying specific weaknesses and providing revised confidence scores. Since the literature provided is quite limited (focusing mainly on sex differences in...
Domain Expert
## PRACTICAL FEASIBILITY ASSESSMENT
Based on the clinical landscape and druggability analysis, I'll assess the three most viable hypotheses:
### **HYPOTHESIS 5: Lactate/Pyruvate Ratio Dynamics in CS...
Synthesizer
```json
{
"ranked_hypotheses": [
{
"title": "Lactate/Pyruvate Ratio Dynamics in CSF as a Neuroinflammation-Metabolism Interface Biomarker",
"description": "Serial measurements of CSF...